(c) 2024 PillSync.com

methylphenidate hydrochloride extendedrelease methylphenidate hydrochloride tablet

1 INDICATIONS AND USAGE Methylphenidate hydrochloride extended-release tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children 6 years of age and older, adolescents, and adults up to the age of 65 [see Clinical Studies ( 14 )] . Methylphenidate hydrochloride extended-release tablets USP are a CNS stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children 6 years of age and older, adolescents, and adults up to the age of 65. ( 1 )

specgx llc


2 months ago OVAL GREY M 27 methylphenidate hydrochloride extendedrelease methylphenidate hydrochloride tablet

OVAL GREY M 27

16 HOW SUPPLIED/STORAGE AND HANDLING Strength Color Tablet Description Bottle Count NDC 27 mg gray capsule shaped, imprinted with “M” in a box and “27” on one side in black ink 100 0406-0127-01 36 mg white capsule shaped, imprinted with “M” in a box and “36” on one side in black ink 100 0406-0136-01 54 mg red capsule shaped, imprinted with “M” in a box and “54” on one side in black ink 100 0406-0154-01 Storage and Handling Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Protect from humidity. Dispense in tight, light-resistant container with child-resistant closure.


More pills like OVAL M 27












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site